Suppr超能文献

一种基于森田-贝利斯-希尔曼反应的合成C-5a链延长的4-表异法戈明型糖苷酶抑制剂的路线。

A Morita-Baylis-Hillman based route to C-5a-chain-extended 4-epi-isofagomine type glycosidase inhibitors.

作者信息

Lebl René, Thonhofer Martin, Tysoe Christina, Pabst Bettina M, Schalli Michael, Weber Patrick, Paschke Eduard, Stütz Arnold E, Tschernutter Marion, Windischhofer Werner, Withers Stephen G

机构信息

Glycogroup, Institute of Organic Chemistry, Graz University of Technology, Stremayrgasse 9, A-8010, Graz, Austria.

Chemistry Department, University of British Columbia, 2036 Main Mall, Vancouver, BC, V6T 1Z1, Canada.

出版信息

Carbohydr Res. 2017 Apr 10;442:31-40. doi: 10.1016/j.carres.2017.03.003. Epub 2017 Mar 6.

Abstract

By Morita-Baylis-Hillman reaction of 2,3-O-isopropylidene-D-glyceraldehyde with α,β-unsaturated carbonyl as well as hetero analogous carbonyl compounds such as acrylonitrile, suitable precursors of isofagomine and of 4-epi-isofagomine are available. Elaboration of the structures by amine introduction, followed by intramolecular ring closure and subsequent hydroboration of the double bond provides 4-epi-isofagomine derivatives featuring chain extensions at C-5a which are determined by the structures of the carbonyl compounds employed. As an example, the synthesis of C-(5aR)- and C-(5aS)-5a-C-pentyl-4-epi-isofagomines, powerful inhibitors of β-galactosidases, is outlined. In line with reported data, the (C-5aR) epimer was found a highly potent experimental pharmacological chaperone for G-associated human lysosomal β-galactosidase mutant R201C.

摘要

通过2,3-O-异亚丙基-D-甘油醛与α,β-不饱和羰基以及杂类似羰基化合物(如丙烯腈)的森田-贝利斯-希尔曼反应,可以得到异法戈明和4-表异法戈明的合适前体。通过引入胺来构建结构,随后进行分子内环合以及对双键进行硼氢化反应,可得到在C-5a处具有链延长的4-表异法戈明衍生物,其链延长情况由所用羰基化合物的结构决定。例如,概述了C-(5aR)-和C-(5aS)-5a-C-戊基-4-表异法戈明的合成,它们是β-半乳糖苷酶的强效抑制剂。与已报道的数据一致,发现(C-5aR)差向异构体是与G相关的人类溶酶体β-半乳糖苷酶突变体R201C的高效实验性药理伴侣。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验